placeholder image
S. A. Irving uri icon qr icon All authors
About me
Publications
selected publications
Journal Article
  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021
    American Journal of Transplantation. 2022
  • Monitoring vaccine safety using the vaccine safety Datalink: assessing capacity to integrate data from Immunization Information systems
    Vaccine. 2022
  • Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Developing algorithms for identifying major structural birth defects using automated electronic health data
    Pharmacoepidemiology and Drug Safety. 2021
  • Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings
    New England Journal of Medicine. 2021
  • Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination
    Vaccine. 2021
  • Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
    Therapeutic advances in drug safety. 2021
  • Uptake and safety of hepatitis A vaccination during pregnancy: a Vaccine Safety Datalink study
    Vaccine. 2019
  • 2015-2016 Vaccine effectiveness of live attenuated and inactivated influenza vaccines in children in the United States
    Clinical Infectious Diseases. 2018
  • Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents
    Pharmacoepidemiology and Drug Safety. 2018
  • Uptake and safety of Hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study
    Vaccine. 2018
  • Risk of anaphylaxis after vaccination in children and adults
    Journal of Allergy and Clinical Immunology. 2016
  • Vaccinations given during pregnancy, 2002-2009: a descriptive study
    American Journal of Preventive Medicine. 2014
  • Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink
    Vaccine. 2013
  • Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010
    Pharmacoepidemiology and Drug Safety. 2013
  • Trivalent inactivated influenza vaccine and spontaneous abortion
    Obstetrics and Gynecology. 2013
  • Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
    Influenza and other respiratory viruses. 2012
  • H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
    American Journal of Preventive Medicine. 2011
  • Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine
    Pediatric Infectious Disease Journal. 2010
  • Contact
    full name
  • S. A. Irving
  • Quick Info
     
    Collaboration